Individualized Therapy Based of Tumoral mRNA Levels of ERCC1, RRM1 and BRCA1 in Advanced Non-Small-Cell Lung Cancer

NCT00705549 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

88

Enrollment

OTHER

Sponsor class

Stopped Due to poor accrual

Conditions

Non-Small-Cell Lung Cancer

Interventions

DRUG: Gemcitabine
DRUG: Cisplatin
DRUG: Docetaxel
DRUG: Cisplatin
DRUG: Vinorelbine
DRUG: Pemetrexate

Sponsor

Hellenic Oncology Research Group

Collaborators

[object Object]